相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CA125 in heart failure: Implications for immunoinflammatory activity
Okan Turgut et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Chromogranin B in Heart Failure A Putative Cardiac Biomarker Expressed in the Failing Myocardium
Helge Rosjo et al.
CIRCULATION-HEART FAILURE (2010)
Statistical methods for assessment of added usefulness of new biomarkers
Michael J. Pencina et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure
Julio Nunez et al.
EUROPEAN HEART JOURNAL (2010)
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine
Mihai Gheorghiade et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial
Helge Rosjo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
CA125 and immunoinflammatory activity in acute heart failure
Gema Minana et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Association of right heart with CA-125 levels in patients with heart failure
Meltem Refiker et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Prognostic value of CA125 in advanced heart failure patients
Silvia Monteiro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival
Okan Turgut et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
S. Bafna et al.
ONCOGENE (2010)
CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma
Yan Yi et al.
BIOMARKERS (2009)
Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome
Luisa De Gennaro et al.
CORONARY ARTERY DISEASE (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Value of BNP and tumour marker CA125 in patients with heart failure
Yang-Xin Chen et al.
ACTA CARDIOLOGICA (2008)
The Chromogranin A-derived vasostatins: New players in the endocrine heart
B. Tota et al.
CURRENT MEDICINAL CHEMISTRY (2008)
CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure
Enrico Vizzardi et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2008)
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism
Tommaso Angelone et al.
ENDOCRINOLOGY (2008)
Serum carbohydrate antigen 125 levels in advanced heart failure: Relation to B-type natriuretic peptide and left atrial volume
Dursun Duman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Heart failure in patients with aortic stenosis: Clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement
Francesco Antonini-Canterin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Elevated CA 125 and ascites: not always malignancy
C. J. Lockhart et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2008)
Carbohydrate antigen 125:: an emerging prognostic risk factor in acute heart failure?
Julio Nunez et al.
HEART (2007)
MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells
Julia R. Davies et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction
Kenan Yalta et al.
ADVANCES IN THERAPY (2006)
Right ventricular dysfunction and adverse outcome in patients with advanced heart failure
Michael E. Field et al.
JOURNAL OF CARDIAC FAILURE (2006)
Tumour markers in chronic heart failure. Review of the literature and clinical implications
Pompilio Faggiano et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Relationship between cytokines and tumour markers in patients with chronic heart failure
F Kosar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
The importance of the gastrointestinal system in the pathogenesis of heart failure
A Krack et al.
EUROPEAN HEART JOURNAL (2005)
Normalization of Cancer Antigen 125 after Mitral Valve Replacement in a Patient with Congestive Heart Failure due to Mitral Valve Endocarditis
Hiroki Sugishita et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2005)
Tumour marker levels in patients with chronic heart failure
E Varol et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters
NT Kouris et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Serum levels of different tumour markers in patients with chronic heart failure
P Faggiano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy - A gynecologic oncology group study
RA Burger et al.
CANCER (2004)
Elevation of the tumor marker CA125 in right heart failure
B Mathew et al.
SOUTHERN MEDICAL JOURNAL (2004)
Serum levels of carbohydrate antigen 125 in patients with chronic heart failure - Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis
A D'Aloia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
The chromogranins: Their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia
SA Feldman et al.
ENDOCRINE PATHOLOGY (2003)
Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening
C Whitehouse et al.
GYNECOLOGIC ONCOLOGY (2003)
Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid
HM Turk et al.
TUMOR BIOLOGY (2003)
Elevated serum CA 125 levels in mitral stenotic patients with heart failure
C Duman et al.
CARDIOLOGY (2003)
Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy
T Schmidt et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
分享论文
